Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Condition: Malignant Mesothelioma
NCT00004254
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.